OMV AG/ AT0000743059 /
03/06/2024 19:53:55 | Chg. +0.040 | Volume | Bid19:53:55 | Ask19:53:55 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
46.320EUR | +0.09% | - Turnover: - |
46.320Bid Size: - | 46.400Ask Size: - | 15.03 bill.EUR | 10.99% | 10.15 |
GlobeNewswire
26/03
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
16/01
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
14/09/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
euro adhoc
13/10/2021
EANS-Adhoc: OMV Aktiengesellschaft / OMV announces redemption of the NC6 Hybrid Notes 2015 EAE
euro adhoc
28/07/2021
EANS-Tip Announcement: OMV Aktiengesellschaft / Half-year financial report according to art. 125 par...
euro adhoc
07/06/2021
EANS-DD: OMV Aktiengesellschaft / Notification concerning transactions by persons performing manager...
euro adhoc
07/06/2021
EANS-DD: OMV Aktiengesellschaft / Notification concerning transactions by persons performing manager...
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center